BILARGY-40 TABLETS

Composition:

Bilastine 40 mg Tablets

Pack Type:

10 X 10

Short Discription:

High-strength Bilastine 40mg tablets for rapid, non-drowsy relief in severe allergic rhinitis, chronic spontaneous urticaria, and refractory skin allergies.

SKU: 4067 Category: Best Biotech Tags: Allergic Dermatitis, Allergy Care, Anti Allergy Tablet, Best Biotech, BILARGY-40 Tablets, Bilastine 40mg, Chronic Spontaneous Urticaria, Derma PCD Franchise, ENT PCD, Non Drowsy Antihistamine, Pharma Franchise India, Pharma PCD, Severe Allergic Rhinitis

BILARGY-40 Tablets (Best Biotech) provide high-potency, non-sedating antihistamine therapy designed for the management of severe or treatment-resistant allergic conditions. Formulated with 40 mg of Bilastine—a novel, highly selective second-generation H-1-receptor antagonist—BILARGY-40 delivers rapid and sustained 24-hour relief from intense allergic inflammation without causing central nervous system depression. Unlike older antihistamines, Bilastine does not undergo hepatic metabolism via the Cytochrome P450 enzyme system and does not cross the blood-brain barrier at therapeutic levels. This ensures an exceptional safety profile with zero psychomotor impairment, no cardiotoxicity, and minimal drug-drug interactions. BILARGY-40 is particularly valuable for patients requiring up-dosed antihistamine therapy for severe chronic spontaneous urticaria (CSU) and intense allergic rhinoconjunctivitis under dermatological and allergy specialist care.

Ultra-Selective H1 Receptor Blockade: Competitively and selectively inhibits peripheral histamine H1 receptors, rapidly arresting histamine-mediated inflammatory responses such as vasodilation, capillary permeability, and sensory nerve stimulation.
Non-Sedating Central Profile: Demonstrates negligible affinity for central H1 receptors, muscarinic receptors, and serotonergic receptors. It avoids drowsiness, dry mouth, or cognitive impairment.
Unchanged Renal/Biliary Excretion: Excreted almost entirely unchanged in urine and feces without relying on hepatic metabolic pathways. This minimizes metabolic burden and avoids interactions with co-administered pharmaceuticals.

Severe or Refractory Chronic Spontaneous Urticaria (CSU)
Severe Seasonal Allergic Rhinitis (Hay Fever)
Perennial Allergic Rhinitis with persistent ocular and nasal symptoms
Allergic Rhinoconjunctivitis (nasal congestion, itching, sneezing, and tearing)
Allergic Rhinoconjunctivitis (nasal congestion, itching, sneezing, and tearing)

Standard Dosage: One tablet (40 mg) once daily, or as strictly prescribed by a Dermatologist, ENT Specialist, or Physician.

Administration: Must be taken on an empty stomach—1 hour before or 2 hours after meals or fruit juice—as food and acidic juices significantly decrease oral bioavailability. Swallow whole with a glass of water.